论文部分内容阅读
目的观察肝病治疗仪联合保肝药物治疗慢性乙型肝炎的临床效果。方法将慢性乙型肝炎患者56例随机分为研究组和对照组各28例。对照组给予保肝药物治疗,研究组给予肝病治疗仪联合保肝药物治疗。对比2组临床疗效和肝功能变化情况。结果研究组总有效率为96.4%高于对照组的67.9%,患者的IBIL、DBIL、TBIL、AST、ALT水平优于对照组,差异均有统计学意义(P<0.05)。结论慢性乙型肝炎经肝病治疗仪联合保肝药物治疗的临床效果十分显著,值得在临床治疗中推广运用。
Objective To observe the clinical effect of liver disease treatment instrument combined with hepatoprotective drugs in the treatment of chronic hepatitis B. Methods 56 patients with chronic hepatitis B were randomly divided into study group and control group of 28 cases. The control group was given hepatoprotective drug treatment, and the study group was given liver disease therapeutic instrument combined with hepatoprotective drug treatment. The clinical efficacy and changes of liver function in two groups were compared. Results The total effective rate was 96.4% in the study group and 67.9% in the control group. The levels of IBIL, DBIL, TBIL, AST and ALT in the study group were better than those in the control group (P <0.05). Conclusions Chronic hepatitis B treatment of liver disease by the combination of hepatoprotective drugs clinical effect is very significant, it is worth to promote the use of clinical treatment.